Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Iwaki Launches Mechanical Ventilators
July 8, 2002
- 1st-Class Products Invite 1st-Class People:Dr Aoki of Fujisawa
July 8, 2002
- REGULATORY NEWS IN BRIEF
July 8, 2002
- Korosho Compiles Report on Healthcare Devices
July 8, 2002
- BULLETIN
July 8, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 8, 2002
- PRESS SEMINAR
July 8, 2002
- Novartis Aims at \70 Bil. Sales of Diovan in 2004
July 8, 2002
- Candesartan Reduces Risk of Non-fatal Stroke in the Elderly
July 8, 2002
- Wako Pure Chemical Starts Contract DNA Sequencing Services
July 8, 2002
- Shareholders' Meetings: Chugai's Merger with Roche Approved
July 8, 2002
- Lasofoxifene Highly Useful for Postmenopausal Diseases
July 8, 2002
- DIAGNOSTIC NEWS IN BRIEF
July 8, 2002
- Wholesalers' Cooperation Is Essential in Immediate PMS: Teijin
July 1, 2002
- Clinical Research GL to Be Compiled by Korosho Working Group
July 1, 2002
- Nippon Chemiphar to Promote Uralyt Based on GLs
July 1, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 1, 2002
- Taiyo Pharm Aims at Sales of Over \20 Bil. in FY2002
July 1, 2002
- PMS Study to Verify Usefulness of Taiho's TS-1
July 1, 2002
- Sales of Radicut Exceed MPC's Expectation
July 1, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…